Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm NCT07410988

Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications

Effect of 130/0.4 Hydroxyethyl Starch vs. Balanced Crystalloid for Intraoperative Fluid Therapy on Major Composite Renal Outcomes After Cardiac Surgery: a Multicenter, Randomized Controlled Trial

Sponsor: Seoul National University Hospital

Conditions Cardiac Surgery

Interventions Crystalloid solutions Volulyte® (6% HES 130/0.4 in balanced solution)

Updated 2 times since 2026 Last updated: Mar 10, 2026 Started: Apr 1, 2026 Primary completion: Mar 31, 2029 Completion: May 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cardiac Surgery, this trial is actively recruiting participants. The trial is conducted by Seoul National University Hospital and has accumulated 2 data snapshots since 2026. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

2 versions recorded

Mar 2026 — Present [monthly]

Not Yet Recruiting PHASE4
Feb 2026 — Mar 2026 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Daejeon, South Korea
• Seoul, South Korea